1-3 of 3
Matthias A. Schweitzer
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Use of an Insulin Bolus Advisor Improves Glycemic Control in Multiple Daily Insulin Injection (MDI) Therapy Patients With Suboptimal Glycemic Control: First results from the ABACUS trial

Ralph Ziegler, MD, David A. Cavan, MD, Iain Cranston, MD, Katharine Barnard, CPSYCHOL, Jacqueline Ryder, RGN, Claudia Vogel, DDB, Christopher G. Parkin, MS, Walter Koehler, MS, Iris Vesper, MS, Bettina Petersen, PHD, Matthias A. Schweitzer, MD, Robin S. Wagner, DVM
Journal: Diabetes Care
Diabetes Care 2013;36(11):3613–3619
https://doi.org/10.2337/dc13-0251
Published: 15 October 2013
View article titled, Use of an Insulin Bolus Advisor Improves Glycemic Control in Multiple Daily Insulin Injection (MDI) Therapy Patients With Suboptimal Glycemic Control: <subtitle>First results from the ABACUS trial</subtitle>
Open the PDF for Use of an Insulin Bolus Advisor Improves Glycemic Control in Multiple Daily Insulin Injection (MDI) Therapy Patients With Suboptimal Glycemic Control: <subtitle>First results from the ABACUS trial</subtitle> in another window
Journal Articles

Changes in A1C Levels Are Significantly Associated With Changes in Levels of the Cardiovascular Risk Biomarker hs-CRP: Results from the SteP study

Oliver Schnell, MD, Ildiko Amann-Zalan, MD, Zhihong Jelsovsky, MS, Annette Moritz, PHD, Justo L. Bermejo, PHD, Christopher G. Parkin, MS, Matthias A. Schweitzer, MD, Lawrence Fisher, PHD, William H. Polonsky, PHD
Journal: Diabetes Care
Diabetes Care 2013;36(7):2084–2089
https://doi.org/10.2337/dc12-1711
Published: 12 June 2013
View article titled, Changes in A1C Levels Are Significantly Associated With Changes in Levels of the Cardiovascular Risk Biomarker hs-CRP: <subtitle>Results from the SteP study</subtitle>
Open the PDF for Changes in A1C Levels Are Significantly Associated With Changes in Levels of the Cardiovascular Risk Biomarker hs-CRP: <subtitle>Results from the SteP study</subtitle> in another window
Journal Articles

Comparison of Basal Insulin Added to Oral Agents Versus Twice-Daily Premixed Insulin as Initial Insulin Therapy for Type 2 Diabetes

Hans U. Janka, MD, Gerd Plewe, MD, Matthew C. Riddle, MD, Christine Kliebe-Frisch, PHD, Matthias A. Schweitzer, MD, Hannele Yki-Järvinen, MD
Journal: Diabetes Care
Diabetes Care 2005;28(2):254–259
https://doi.org/10.2337/diacare.28.2.254
Published: 01 February 2005
View article titled, Comparison of Basal Insulin Added to Oral Agents Versus Twice-Daily Premixed Insulin as Initial Insulin Therapy for Type 2 Diabetes
Open the PDF for Comparison of Basal Insulin Added to Oral Agents Versus Twice-Daily Premixed Insulin as Initial Insulin Therapy for Type 2 Diabetes in another window